Tvardi Therapeutics, Inc. SEC filings TVRD

Tvardi Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Dec 6, 2005. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Tvardi Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
Regulation FD disclosure
Jul 30, 2026 Jul 30, 2026
8-K Current report
Other events
Jul 17, 2026 Jul 17, 2026
424B5 Prospectus supplement Jul 17, 2026 —
8-K Current report
Regulation FD disclosure
Jul 7, 2026 Jul 7, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 9, 2026
EFFECT Filing May 13, 2026 —
EFFECT Filing May 12, 2026 —
POS AM Filing May 8, 2026 —
CORRESP Letter to the SEC May 8, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
UPLOAD Letter from the SEC May 7, 2026 —
S-3 Shelf registration May 1, 2026 —
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 9, 2026
S-8 Employee stock plan registration Apr 1, 2026 —
POS EX Filing Apr 1, 2026 —
424B3 Prospectus Apr 1, 2026 —
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
424B3 Prospectus Mar 6, 2026 —
8-K Current report
Other events
Mar 6, 2026 Mar 6, 2026
8-K Current report
Regulation FD disclosure
Jan 16, 2026 Jan 16, 2026
8-K Current report
Officer or director change
Dec 18, 2025 Dec 16, 2025
8-K Current report
Regulation FD disclosure
Nov 19, 2025 Nov 19, 2025
424B3 Prospectus Nov 13, 2025 —
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
S-8 Employee stock plan registration Oct 20, 2025 —
S-1/A Amended registration statement Oct 20, 2025 —
8-K Current report
Other events
Oct 14, 2025 Oct 13, 2025
S-1/A Amended registration statement Oct 7, 2025 —
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Jul 14, 2025 Jul 8, 2025
8-K Current report
Other events
Jun 9, 2025 Jun 6, 2025
UPLOAD Letter from the SEC Jun 5, 2025 —
S-1 Registration statement May 30, 2025 —
8-K Current report
Regulation FD disclosure
May 27, 2025 May 27, 2025
8-K Current report
Results of operations, Auditor change
May 13, 2025 May 12, 2025
8-K/A Amended current report
Acquisition or sale of assets
May 13, 2025 Apr 15, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Apr 15, 2025 Apr 15, 2025
8-K Current report
Regulation FD disclosure
Apr 11, 2025 Apr 11, 2025
8-K Current report
Shareholder vote results, Other events
Apr 1, 2025 Apr 1, 2025
425 Filing Mar 24, 2025 —
8-K Current report
Other events
Mar 24, 2025 Mar 24, 2025
10-K Annual report Mar 11, 2025 Dec 31, 2024
SEC STAFF LETTER Filing Feb 14, 2025 —
EFFECT Filing Feb 14, 2025 —
424B3 Prospectus Feb 14, 2025 —
CORRESP Letter to the SEC Feb 14, 2025 —
S-4/A Filing Feb 14, 2025 —
CORRESP Letter to the SEC Feb 13, 2025 —
UPLOAD Letter from the SEC Feb 11, 2025 —
S-4/A Form s-4/a Jan 27, 2025 —
CORRESP Letter to the SEC Jan 24, 2025 —
425 Filing Jan 21, 2025 —
8-K Current report
Regulation FD disclosure
Jan 21, 2025 Jan 16, 2025
425 Filing Jan 17, 2025 —
8-K Current report
Other events
Jan 17, 2025 Jan 14, 2025
SEC STAFF LETTER Filing Jan 16, 2025 —
UPLOAD Letter from the SEC Jan 16, 2025 —
425 Filing Dec 30, 2024 —
8-K Current report
Bylaw or fiscal year change
Dec 30, 2024 Dec 30, 2024
425 Filing Dec 20, 2024 —
8-K/A Amended current report Dec 20, 2024 Dec 17, 2024
S-4 Registration for a merger or exchange Dec 18, 2024 —
425 Filing Dec 18, 2024 —
8-K Current report
Material agreement, Change in control, Officer or director change, Other events
Dec 18, 2024 Dec 17, 2024
8-K Current report
Listing notice
Nov 22, 2024 Nov 19, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Listing notice
Aug 1, 2024 Jul 31, 2024
8-K Current report
Exit or restructuring costs
Jun 18, 2024 Jun 14, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 12, 2024 Jun 12, 2024
424B5 Prospectus supplement Jun 7, 2024 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 7, 2024 Jun 4, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
DEFA14A Additional proxy material Apr 22, 2024 —
ARS Annual report to shareholders Apr 22, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 22, 2024 Jun 4, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 Jun 4, 2024
8-K Current report
Officer or director change
Mar 22, 2024 Mar 19, 2024
S-8 Employee stock plan registration Mar 6, 2024 —
10-K Annual report Mar 6, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 4, 2024 Mar 4, 2024
8-K Current report
Listing notice
Feb 2, 2024 Feb 1, 2024
8-K Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
Jan 22, 2024 Jan 17, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 18, 2023 Dec 18, 2023
8-K Current report
Regulation FD disclosure
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Nov 2, 2023 Nov 1, 2023
8-K Current report
Regulation FD disclosure
Aug 7, 2023 Aug 7, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 3, 2023 Aug 2, 2023
8-K Current report
Shareholder vote results
Jun 2, 2023 Jun 1, 2023
8-K Current report
Regulation FD disclosure
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 Jun 1, 2023
8-K Current report
Regulation FD disclosure
Mar 23, 2023 Mar 23, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
S-8 Employee stock plan registration Mar 6, 2023 —
10-K Annual report Mar 6, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 6, 2023 Mar 6, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Regulation FD disclosure
Nov 7, 2022 Nov 7, 2022
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 3, 2022 Nov 1, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 12, 2022 Sep 12, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Regulation FD disclosure
Aug 8, 2022 Aug 8, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2022 Jun 28, 2022
8-K Current report
Shareholder vote results
Jun 7, 2022 Jun 2, 2022
8-K Current report
Officer or director change
Jun 3, 2022 May 27, 2022
EFFECT Filing May 11, 2022 —
CORRESP Letter to the SEC May 9, 2022 —
S-3/A Filing May 9, 2022 —
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
CORRESP Letter to the SEC Apr 26, 2022 —
CORRESP Letter to the SEC Apr 22, 2022 —
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 2, 2022
8-K Current report
Regulation FD disclosure
Mar 11, 2022 Mar 11, 2022
UPLOAD Letter from the SEC Mar 8, 2022 —
S-3 Shelf registration Mar 1, 2022 —
S-8 Employee stock plan registration Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Dec 21, 2021 Dec 15, 2021
8-K Current report
Regulation FD disclosure, Other events
Dec 20, 2021 Dec 20, 2021
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 3, 2021 Oct 28, 2021
8-K Current report
Other events
Aug 31, 2021 Aug 30, 2021
8-K Current report
Other events
Aug 23, 2021 Aug 23, 2021
8-K Current report
Regulation FD disclosure
Aug 12, 2021 Aug 12, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Material agreement
Aug 4, 2021 Jul 26, 2021
8-K Current report
Shareholder vote results
Jun 7, 2021 Jun 3, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
8-K Current report
Regulation FD disclosure, Other events
Apr 29, 2021 Apr 29, 2021
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 3, 2021
8-K Current report
Regulation FD disclosure
Mar 30, 2021 Mar 30, 2021
8-K Current report
Regulation FD disclosure
Mar 8, 2021 Mar 8, 2021
S-8 Employee stock plan registration Mar 1, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Regulation FD disclosure
Dec 28, 2020 Dec 28, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 20, 2020 Oct 15, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 1, 2020 Oct 1, 2020
8-K/A Amended current report
Shareholder vote results
Aug 11, 2020 Jun 4, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Officer or director change
Jun 30, 2020 Jun 26, 2020
8-K Current report
Other events
Jun 17, 2020 Jun 17, 2020
8-K Current report
Shareholder vote results
Jun 5, 2020 Jun 4, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEFA14A Additional proxy material Apr 22, 2020 —
DEF 14A Proxy statement Apr 22, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure, Other events
Apr 21, 2020 Apr 21, 2020
8-K Current report
Other events
Mar 25, 2020 Mar 25, 2020
S-8 Employee stock plan registration Feb 28, 2020 —
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
SEC STAFF LETTER Filing Feb 18, 2020 —
SEC STAFF LETTER Filing Feb 5, 2020 —
8-K Current report
Regulation FD disclosure
Jan 14, 2020 Jan 14, 2020
8-K Current report
Officer or director change
Dec 23, 2019 Dec 17, 2019
8-K Current report
Regulation FD disclosure
Dec 16, 2019 Dec 16, 2019
8-K Current report
Regulation FD disclosure, Other events
Dec 3, 2019 Dec 3, 2019
S-8 Employee stock plan registration Nov 20, 2019 —
8-K Current report
Other events
Nov 20, 2019 Nov 20, 2019
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
S-3ASR Automatic shelf registration Sep 9, 2019 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 21, 2019 Aug 20, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Other events
Jul 29, 2019 Jul 24, 2019
424B5 Prospectus supplement Jul 25, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TVRD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Sugar Land, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1346830
Former names
Cara Therapeutics, Inc. (until Apr 11, 2025); Cara Therapeutics Inc (until Jul 21, 2010)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.